Liver Health Policy Updates - Global Liver Institute

Advances in Liver Cancer Treatment & Research – Liver Cancer News

Mar 3, 2025

Liver cancer continues to be a growing public health concern, with new research and treatment innovations shaping the future of care. This newsletter brings you the latest advancements in the field, including promising therapies, diagnostic breakthroughs, and discussions on the rising impact of metabolic and alcohol-related liver diseases. Stay informed with expert insights and emerging strategies that could improve patient outcomes.

How the Hepatitis C Cure Affects Other Chronic Conditions

Feb 12, 2025

Hepatitis C infection is a chronic infection of the liver by the hepatitis C virus (HCV) that continues to affect millions of people across the globe. Left untreated, infection with hepatitis C leads to worsening liver damage and puts the body in distress, which can lead to brain fog, abdominal pain, and internal bleeding.

New Administration, New Congress, and Their Health Priorities Just Starting to Take Shape – Liver Health Policy Update

Feb 7, 2025

The new U.S. Congress is at work in Washington, DC. It is unclear if the healthcare legislation that came so close to passage last December will be included in a March appropriations package.

It’s Rare Liver Diseases Month! – Pediatric & Rare Liver Diseases News

Feb 6, 2025

February is Rare Liver Diseases Month! This year, our campaign is shining a spotlight on Rare and Rural.

Latest Developments in Treatments – Liver Cancer News

Feb 4, 2025

In recent years, liver cancer has emerged as a significant global health concern, with increasing incidence rates and a pressing need for innovative treatment strategies.

What’s New in 2025 – Fatty Liver Disease News

Feb 3, 2025

As of January 2025, major changes to Medicare Part D under the Inflation Reduction Act are now in effect, making prescription drugs more affordable for millions of patients.

Rural Communities at Risk: Global Liver Institute Champions Awareness for Rare Liver Diseases

Feb 1, 2025

As rural healthcare access shrinks across the United States and remains limited worldwide, Global Liver Institute (GLI) is shining a spotlight on the critical need for awareness and education about rare liver diseases during Rare Liver Diseases Month.

Global Liver Institute Supports CMS Coverage of Obesity Medications

Jan 22, 2025

GLI was very pleased to see the U.S. Centers for Medicare and Medicaid Services (CMS) take the step towards expanding coverage for anti-obesity medications when used to treat obesity in the Medicare Part D and Medicaid programs.

Global Liver Institute Statement on U.S. End-of-Year Health Package

Dec 18, 2024

GLI celebrates the release of bill text last night for a continuing resolution (CR) for FY2025 from the U.S. House of Representatives that includes Medicare coverage of multi-cancer early detection screening tests and defines standards and payments for these diagnostic tests.

The Case for Universal Access to Hepatitis C DAA Treatment for Your Patients

Dec 9, 2024

Hepatitis C is a viral infection of the liver caused by the hepatitis C virus (HCV) and spread through blood-to-blood exposure. The majority of people exposed to HCV develop chronic infection, which can cause cirrhosis resulting in liver failure, liver cancer, or even the need for liver transplantation.

Can Blood Tests Help Predict Liver Transplant Outcomes? – Pediatric & Rare Liver Diseases News

Dec 6, 2024

As we conclude this year, the Pediatric and Rare Liver Diseases team is reflecting on the incredible progress made by our council and patient organizations in 2024.

Congress debates appropriations and other end-of-year legislation. Biden administration issues more rulemakings. Agencies prepare for new leadership. – Liver Health Policy Update

Dec 5, 2024

Members of Congress have returned to Washington, DC. It is unclear if many healthcare priorities will make it to final passage this year. The incoming administration has submitted names for its new Cabinet and to lead key agencies.